BioSpace News Archive

Lone Star Bio

Retrospective Study of Seno Medical’s Imagio® Breast Imaging System Published in American Journal of Roentgenology Shows System May Help Reduce Biopsies of Benign Breast Masses Compared to Ultrasound Alone

A retrospective study of Seno Medical‘s Imagio® Breast Imaging System published in the American Journal of Roentgenology found that the company’s opto-acoustic/ultrasound technology significantly improves specificity at fixed sensitivity compared to conventional ultrasound.

January 5, 2023
·
4 min read
Precision BioLogic’s Chromogenic FIX Assay FDA-Cleared for Sale in U.S.

Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce FDA 510(k) clearance and the launch of its new CRYOcheck™ Chromogenic Factor IX assay in the U.S.

January 5, 2023
·
4 min read
Pharm Country

Panavance Therapeutics to Present at the Virtual Investor 2023 Companies to Watch Event

Panavance Therapeutics Inc. today announced that Greg Bosch, Chairman and CEO of Panavance Therapeutics will present at the Virtual Investor 2023 Companies to Watch Event on Wednesday, January 18, 2023.

January 5, 2023
·
2 min read
Drug Development

Ovid Therapeutics Dosed Healthy Volunteers with OV329 in Phase 1 TrialA Potential, Next-Generation GABA-Aminotransferase Inhibitor for Rare Epilepsies with Limited Treatment Options

Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing medicines designed to conquer epilepsies and meaningfully improve the lives of people affected by brain disorders, dosed healthy volunteers with OV329 in late December 2022, as part of a Phase 1 study.

January 5, 2023
·
6 min read
Genetown

Noema Pharma to Attend and Present at 41st Annual J.P. Morgan Healthcare Conference in San Francisco

Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) disorders, announced that members of the Management Team will attend and present at the 41st Annual J.P. Morgan Healthcare Conference taking place on January 9-12, 2023 in San Francisco, CA.

January 5, 2023
·
1 min read
Drug Development

Inspirna Announces Interim Data from Phase 1b/2 Study of Abequolixron (RGX-104) in Relapsed or Refractory Lung Cancer

Inspirna Announces Interim Data from Phase 1b/2 Study of Abequolixron (RGX-104) in Relapsed or Refractory Lung Cancer.

January 5, 2023
·
6 min read
Vivos Therapeutics Announces Pricing of $8 Million Private Placement

Vivos Therapeutics, Inc. today announced that it has entered into a definitive agreement with a single institutional investor to raise approximately $8 million in a private placement offering at a price of $1.20 per unit.

January 5, 2023
·
4 min read
Business

X-Chem and Sironax Begin Neurodegenerative Disease Drug Discovery Research Partnership

X-Chem today announces the establishment of a research partnership with Sironax, in which X-Chem will leverage its powerful DEL platform to support Sironax’s drug discovery pipeline.

January 5, 2023
·
2 min read
XAV-19, the anti-SARS-CoV-2 GH-pAb of XENOTHERA best-in-class against all variants including BQ. 1.1

In the context of a major resurgence of the COVID epidemic, the French biotech XENOTHERA announces recent data in favor of the strong interest of its glyco-humanized polyclonal antibody (GH-pAb) XAV-19 to treat patients in the initial viral phase of the disease.

January 5, 2023
·
3 min read
Genetown

How Merck Is Prioritizing Diversity in Clinical Trials and Why It’s So Important

Different people may have different reactions to the same medicines and vaccines based on their age, gender, weight, race, ethnicity, geography or other factors.

January 5, 2023
·
2 min read